{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T05:12:17Z","timestamp":1774674737232,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Micell Technologies Incorporated"},{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Boston Scientific"},{"name":"Micell Technologies"},{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Boston Scientific"},{"name":"Medtronic Cardiovascular"},{"name":"Elixir"},{"name":"Stentys"},{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Boston Scientific"},{"name":"Medtronic Cardiovascular"},{"name":"Micell Technologies"},{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"crossref"}]},{"name":"AstraZeneca"},{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Boston Scientific"},{"name":"Cardio3Biosciences"},{"name":"Cordis"},{"name":"Medtranic"},{"name":"Orbus Neich"},{"DOI":"10.13039\/100006279","name":"St. Jude Medical","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006279","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008645","name":"Terumo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008645","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Therabel"},{"name":"Tryton Medical"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.jcin.2013.05.013","type":"journal-article","created":{"date-parts":[[2013,9,18]],"date-time":"2013-09-18T13:46:41Z","timestamp":1379512001000},"page":"1026-1034","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["First-in-Human Evaluation of a Bioabsorbable Polymer\u2013Coated Sirolimus-Eluting Stent"],"prefix":"10.1016","volume":"6","author":[{"given":"John","family":"Ormiston","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Webster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Vrolix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Whitbourn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Donohoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlene","family":"Knape","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Lansky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilherme F.","family":"Attizzani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Kandzari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Wijns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2013.05.013_bib1","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa012843","article-title":"A\u00a0randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization","volume":"346","author":"Morice","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2013.05.013_bib2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa032441","article-title":"A\u00a0polymer-based, paclitaxel-eluting stent in patients with coronary artery disease","volume":"350","author":"Stone","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2013.05.013_bib3","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.amjcard.2005.01.040","article-title":"Drug-eluting stents versus bare metal stents in percutaneous coronary interventions (a meta-analysis)","volume":"95","author":"Indolfi","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2013.05.013_bib4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jacc.2005.07.071","article-title":"Hypersensitivity cases associated with drug-eluting coronary stents. a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) Project","volume":"47","author":"Nebeker","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2013.05.013_bib5","first-page":"2061","article-title":"In-stent neoatherosclerosis. A final common pathway of late stent failure","volume":"59","author":"Park","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2013.05.013_bib6","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1093\/eurheartj\/ehl282","article-title":"Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis","volume":"27","author":"Nordmann","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2013.05.013_bib7","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/CIRCINTERVENTIONS.110.946426","article-title":"Six-month results of the NEVO Res-Elution I (NEVO RES-I) trial: a randomized, multicenter comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Libert\u00e9 paclitaxel-eluting stent in de novo native coronary artery lesions","volume":"3","author":"Ormiston","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2013.05.013_bib8","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4244\/EIJV7I4A81","article-title":"Clinical performance of drug-eluting stents with biodegradable polymeric coating: a meta-analysis and systematic review","volume":"7","author":"Ahmed","year":"2011","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2013.05.013_bib9","first-page":"1940","article-title":"Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularization (LEADERS): a randomized non-inferiority trial","volume":"378","author":"Windecker","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2013.05.013_bib10","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1093\/eurheartj\/ehs086","volume":"33","author":"Stefanini","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2013.05.013_bib11","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jcin.2011.06.017","article-title":"Dual antiplatelet therapy duration and clinical outcomes following treatment with zotarolimus-eluting stents","volume":"4","author":"Kandzari","year":"2011","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2013.05.013_bib12","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/eurheartj\/ehs460","article-title":"Should duration of dual antiplatelet therapy depend on the type and\/or potency of implanted stent? A prespecified analysis from the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY)","volume":"34","author":"Valgimigli","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2013.05.013_bib13","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jconrel.2012.07.004","article-title":"Enhanced drug delivery capabilities from stents coated with absorbable polymer and crystalline drug","volume":"162","author":"Carlyle","year":"2012","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.jcin.2013.05.013_bib14","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/01.CIR.82.4.1193","article-title":"Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group","volume":"82","author":"Ellis","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2013.05.013_bib15","first-page":"560","article-title":"Serial Evaluation of Vascular Response After Implantation of a New Sirolimus-Eluting Stent With Bioabsorbable Polymer (MISTENT): an optical coherence tomography and histopathological study","volume":"24","author":"Attizzani","year":"2012","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.jcin.2013.05.013_bib16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4244\/EIJV5I2A35","article-title":"Reproducibility of quantitative optical coherence tomography for stent analysis","volume":"5","author":"Gonzalo","year":"2009","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2013.05.013_bib17","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2013.05.013_bib18","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jcin.2011.11.002","article-title":"Stent longitudinal integrity bench insights into a clinical problem","volume":"4","author":"Ormiston","year":"2011","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2013.05.013_bib19","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1536\/ihj.50.811","article-title":"Long-term effects of novel biodegradable, polymer-coated, sirolimus-eluting stents on neointimal formation in a porcine coronary model","volume":"50","author":"Peng","year":"2009","journal-title":"Int Heart J"},{"key":"10.1016\/j.jcin.2013.05.013_bib20","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.jacc.2006.10.026","article-title":"Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents","volume":"48","author":"Pfisterer","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2013.05.013_bib21","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1056\/NEJMoa067731","article-title":"Stent thrombosis in randomized clinical trials of drug-eluting stents","volume":"356","author":"Mauri","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2013.05.013_bib22","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1161\/CIRCULATIONAHA.106.675934","article-title":"Drug-eluting stents and coronary thrombosis: biological mechanisms and clinical implications","volume":"115","author":"Luscher","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2013.05.013_bib23","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jacc.2007.06.002","article-title":"Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions","volume":"50","author":"Jensen","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2013.05.013_bib24","first-page":"A411","article-title":"Evolving DES platforms","volume":"122","author":"Virmani","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2013.05.013_bib25","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1161\/CIRCULATIONAHA.107.693739","article-title":"Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization","volume":"115","author":"Finn","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2013.05.013_bib26","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.jacc.2006.08.035","article-title":"Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial","volume":"48","author":"Kandzari","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2013.05.013_bib27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(09)62127-9","article-title":"Second generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial","volume":"375","author":"Kedhi","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2013.05.013_bib28","doi-asserted-by":"crossref","first-page":"45M","DOI":"10.1016\/j.amjcard.2007.08.021","article-title":"Zotarolimus-eluting stents in patients with native coronary artery disease: clinical and angiographic outcomes in 1,317 patients","volume":"100","author":"Gershlick","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2013.05.013_bib29","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(12)60324-9","article-title":"Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis","volume":"379","author":"Palmerini","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2013.05.013_bib30","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/S0140-6736(12)60440-1","article-title":"Stent thrombosis: has the firestorm been extinguished?","volume":"379","author":"Ormiston","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2013.05.013_bib31","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1161\/CIRCULATIONAHA.110.004762","article-title":"Five-year clinical and angiographic outcomes of a randomized comparison of sirolimus-eluting and paclitaxel-eluting stents: results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE trial","volume":"123","author":"R\u00e4ber","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2013.05.013_bib32","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1161\/CIRCULATIONAHA.111.046599","article-title":"Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry","volume":"125","author":"Kimura","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2013.05.013_bib33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jacc.2011.02.022","article-title":"Randomized comparison of everolimus- and paclitaxel-eluting stents. 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial","volume":"58","author":"Stone","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2013.05.013_bib34","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1161\/CIRCULATIONAHA.111.063644","article-title":"Randomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: the Scandinavian Organization for Randomized Trials with Clinical Outcome IV (SORT OUT IV)","volume":"125","author":"Jensen","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2013.05.013_bib35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jcin.2011.09.018","article-title":"Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging","volume":"5","author":"Guagliumi","year":"2012","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2013.05.013_bib36","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jacc.2010.05.066","article-title":"Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents","volume":"57","author":"Nakazawa","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2013.05.013_bib37","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jacc.2011.01.011","article-title":"The pathology of neoatherosclerosis in human coronary implants. Bare-metal and drug-eluting stents","volume":"57","author":"Nakazawa","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2013.05.013_bib38","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(11)61672-3","article-title":"Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial","volume":"378","author":"Stefanini","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2013.05.013_bib39","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(12)61962-X","article-title":"Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomized non-inferiority trial","volume":"381","author":"Chistiansen","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2013.05.013_bib40","doi-asserted-by":"crossref","first-page":"985","DOI":"10.4244\/EIJV7I8A155","article-title":"Safety and efficacy of biodegradable vs. durable polymer drug-eluting stents: evidence from a meta-analysis of randomised trials","volume":"7","author":"Navarese","year":"2011","journal-title":"EuroIntervention"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879813012272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879813012272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:59:09Z","timestamp":1761847149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879813012272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1936879813012272"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2013.05.013","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First-in-Human Evaluation of a Bioabsorbable Polymer\u2013Coated Sirolimus-Eluting Stent","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2013.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}